460 related articles for article (PubMed ID: 24007137)
21. Dosimetric Considerations for Ytterbium-169, Selenium-75, and Iridium-192 Radioisotopes in High-Dose-Rate Endorectal Brachytherapy.
Shoemaker T; Vuong T; Glickman H; Kaifi S; Famulari G; Enger SA
Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):875-883. PubMed ID: 31330175
[TBL] [Abstract][Full Text] [Related]
22. Modeling of the direction modulated brachytherapy tandem applicator using the Oncentra Brachy advanced collapsed cone engine.
Safigholi H; van Veelen B; Niatsetski Y; Song WY
Brachytherapy; 2018; 17(6):1030-1036. PubMed ID: 30181054
[TBL] [Abstract][Full Text] [Related]
23. Dosimetric optimization of a conical breast brachytherapy applicator for improved skin dose sparing.
Yang Y; Rivard MJ
Med Phys; 2010 Nov; 37(11):5665-71. PubMed ID: 21158278
[TBL] [Abstract][Full Text] [Related]
24. Design and evaluation of 3D printable patient-specific applicators for gynecologic HDR brachytherapy.
Semeniuk O; Cherpak A; Robar J
Med Phys; 2021 Jul; 48(7):4053-4063. PubMed ID: 33880777
[TBL] [Abstract][Full Text] [Related]
25. Attenuation of intracavitary applicators in 192Ir-HDR brachytherapy.
Ye SJ; Brezovich IA; Shen S; Duan J; Popple RA; Pareek PN
Med Phys; 2004 Jul; 31(7):2097-106. PubMed ID: 15305463
[TBL] [Abstract][Full Text] [Related]
26. Direction modulated brachytherapy (DMBT) tandem applicator for cervical cancer treatment: Choosing the optimal shielding material.
Safigholi H; Han DY; Soliman A; Song WY
Med Phys; 2018 Jun; ():. PubMed ID: 29858499
[TBL] [Abstract][Full Text] [Related]
27. HDRMC, an accelerated Monte Carlo dose calculator for high dose rate brachytherapy with CT-compatible applicators.
Chibani O; C-M Ma C
Med Phys; 2014 May; 41(5):051712. PubMed ID: 24784378
[TBL] [Abstract][Full Text] [Related]
28. Needle-free cervical cancer treatment using helical multishield intracavitary rotating shield brachytherapy with the
Hopfensperger KM; Adams Q; Kim Y; Wu X; Xu W; Patwardhan K; Thammavong B; Caster J; Flynn RT
Med Phys; 2020 Jun; 47(5):2061-2071. PubMed ID: 32073669
[TBL] [Abstract][Full Text] [Related]
29. Dosimetric characterization and output verification for conical brachytherapy surface applicators. Part II. High dose rate 192Ir sources.
Fulkerson RK; Micka JA; DeWerd LA
Med Phys; 2014 Feb; 41(2):022104. PubMed ID: 24506636
[TBL] [Abstract][Full Text] [Related]
30. Direction Modulated Brachytherapy for Treatment of Cervical Cancer. II: Comparative Planning Study With Intracavitary and Intracavitary-Interstitial Techniques.
Han DY; Safigholi H; Soliman A; Ravi A; Leung E; Scanderbeg DJ; Liu Z; Owrangi A; Song WY
Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):440-448. PubMed ID: 27598809
[TBL] [Abstract][Full Text] [Related]
31. Design and Development of In-House Multichannel Applicator for HDR Vaginal Brachytherapy and Dosimetric Comparision with Single Channel Applicator.
Govindaraj K; Shanmugam S; Sampathrajan S
Asian Pac J Cancer Prev; 2019 Dec; 20(12):3805-3810. PubMed ID: 31870125
[TBL] [Abstract][Full Text] [Related]
32. The importance of applicator design for intraluminal brachytherapy of rectal cancer.
Hansen JW; Jakobsen A
Med Phys; 2006 Sep; 33(9):3220-4. PubMed ID: 17022215
[TBL] [Abstract][Full Text] [Related]
33. Design and dose distribution for rectal applicators for the high dose rate remote afterloading iridium-192 brachytherapy system.
Kennedy DK; Klonowski LM; Wade RF; Sanwalani SC; Yalavarthi SD
Med Dosim; 1989 Sep; 14(3):209-18. PubMed ID: 2604856
[TBL] [Abstract][Full Text] [Related]
34. Dosimetric optimization of a colpostat in a 60Co high-dose-rate brachytherapy unit for bladder sparing.
Zakariaee SS; Mahdavi SR
Brachytherapy; 2015; 14(1):37-45. PubMed ID: 25260688
[TBL] [Abstract][Full Text] [Related]
35. Advantages of inflatable multichannel endorectal applicator in the neo-adjuvant treatment of patients with locally advanced rectal cancer with HDR brachytherapy.
Devic S; Vuong T; Moftah B
J Appl Clin Med Phys; 2005; 6(2):44-9. PubMed ID: 15940211
[TBL] [Abstract][Full Text] [Related]
36. On the validity of the superposition principle in dose calculations for intracavitary implants with shielded vaginal colpostats.
Markman J; Williamson JF; Dempsey JF; Low DA
Med Phys; 2001 Feb; 28(2):147-55. PubMed ID: 11243337
[TBL] [Abstract][Full Text] [Related]
37. Comparison of 2D vs. 3D dosimetry for Rotte 'Y' applicator high dose rate brachytherapy for medically inoperable endometrial cancer.
Beriwal S; Kim H; Heron DE; Selvaraj R
Technol Cancer Res Treat; 2006 Oct; 5(5):521-7. PubMed ID: 16981795
[TBL] [Abstract][Full Text] [Related]
38. HDR Brachytherapy Dose Distribution is Influenced by the Metal Material of the Applicator.
Wu CH; Liao YJ; Shiau AC; Lin HY; Hsueh Liu YW; Hsu SM
Sci Rep; 2015 Dec; 5():17863. PubMed ID: 26658746
[TBL] [Abstract][Full Text] [Related]
39. Dosimetric comparison of (192)Ir high-dose-rate brachytherapy vs. 50 kV x-rays as techniques for breast intraoperative radiation therapy: conceptual development of image-guided intraoperative brachytherapy using a multilumen balloon applicator and in-room CT imaging.
Jones R; Libby B; Showalter SL; Brenin DR; Wilson DD; Schroen A; Morris M; Reardon KA; Morrison J; Showalter TN
Brachytherapy; 2014; 13(5):502-7. PubMed ID: 24933339
[TBL] [Abstract][Full Text] [Related]
40. Interstitial rotating shield brachytherapy for prostate cancer.
Adams QE; Xu J; Breitbach EK; Li X; Enger SA; Rockey WR; Kim Y; Wu X; Flynn RT
Med Phys; 2014 May; 41(5):051703. PubMed ID: 24784369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
